Cardiology

Everyday medical support built on trust, quality checkups, and personal attention to your overall wellness.

Illustration representing TAVR authorization and hemodynamic data workflow in a structural heart program

Cardiology TAVR Authorization & Hemodynamic Data: The 2026 Operations Playbook for Structural Heart Programs

  • Hemodynamic Symmetry: The Gate Your Auth Must Pass

  • Paradoxical Low-Flow/Low-Gradient AS: Forensic Logic for Denial Prevention

  • FHIR R4 Data Pipeline: Echo SR to Prior-Auth Packet

  • SB 1120 Human-Review Compliance & Provenance Chain

  • ICD-10 / CPT Mapping Matrix for TAVR Submissions

  • CT Calcium Score Integration via DICOMweb

  • Clinical Workflow Timeline: 24-Hour Approval Path

  • ROI & Denial-Cost Analysis for Structural Heart Programs

  • Expert Audit Defense: Documentation That Survives Post-Pay Review

Hemodynamic Symmetry: The Gate Your Auth Must Pass

CLINICAL UPDATE JUNE 2026: Revised for CMS Transmittal 12714 (eff. April 2026), updated SB 1120 human-review mandates in CA/CO/IL, and FHIR R4 v6.0.0 DiagnosticReport mapping for Echo structured reports.

Hemodynamic Symmetry is the payer-side logic test that determines whether echocardiographic parameters in your TAVR prior-authorization submission are internally consistent and satisfy medical necessity. For CPT 33361 (transcatheter aortic valve replacement, transfemoral approach), every major commercial and Medicare Advantage plan now algorithmically validates that the mean pressure gradient and aortic valve area corroborate severe AS—not just individually, but as a concordant dataset.

Scribing.io was purpose-built to enforce Hemodynamic Symmetry before your packet leaves the building. The platform auto-extracts gradient and AVA values from the Echo structured report (FHIR DiagnosticReport), flags discordance patterns that trigger payer denials, and routes confirmatory evidence—CT calcium scoring, dobutamine stress echo, or SVI calculations—into the submission without manual chart pulls.

The clinical stakes are unambiguous: a denied or delayed TAVR authorization for a symptomatic severe AS patient (NYHA Class III–IV) carries a 30-day mortality risk of 4.1% in octogenarians and a re-admission probability exceeding 38% for decompensated heart failure. Every day of delay matters. This playbook gives your structural heart team the exact technical framework to eliminate preventable denials.

Paradoxical Low-Flow/Low-Gradient AS: Forensic Logic for Denial Prevention

Paradoxical low-flow/low-gradient (LFLG) aortic stenosis is the single most denied TAVR indication in 2026 payer data. The patient phenotype—preserved ejection fraction (≥50%), low stroke volume index (<35 mL/m²), low mean gradient (<40 mmHg), and small AVA (<1.0 cm²)—creates a data pattern that payer algorithms interpret as "discordant" and auto-flag for additional review or outright denial.

The Index Case: 82-Year-Old With Paradoxical LFLG AS

Consider the exact scenario structural heart coordinators encounter weekly: an 82-year-old male, EF 60%, stroke volume index 28 mL/m², mean gradient 32 mmHg, AVA 0.7 cm². He meets ACC/AHA 2024 criteria for severe AS by AVA and SVi-adjusted thresholds, yet his mean gradient is below the 40 mmHg classical cutoff. The initial TAVR authorization (CPT 33361) is denied because the submission presented the gradient and AVA without confirmatory evidence reconciling the discordance.

This is a Hemodynamic Symmetry failure—not a clinical failure. The payer's utilization review algorithm saw a mean gradient of 32 mmHg (below severe threshold) paired with an AVA of 0.7 cm² (below severe threshold) and flagged the asymmetry. Without attached evidence explaining the low-flow physiology, the algorithm treated the gradient as the governing parameter and classified the stenosis as "moderate."

How Scribing.io Resolved This in 24 Hours

  • Auto-detection of LFLG criteria: Scribing.io ingested the Echo structured report via FHIR R4 DiagnosticReport (resource ID: DiagnosticReport/echo-as-eval) and identified the SVi < 35 mL/m², EF ≥ 50%, AVA < 1.0 cm², and mean gradient < 40 mmHg pattern. The system classified this as "Paradoxical LFLG AS—Confirmatory Evidence Required" within 90 seconds of report finalization.

  • Automated CT calcium score retrieval: Scribing.io queried PACS via DICOMweb WADO-RS to pull the most recent non-contrast cardiac CT. The Agatston calcium score of 2100 in a male patient exceeded the sex-specific severe threshold (≥2000 for males per 2024 ACC/AHA and 2026 CMS LCD L39365), confirming severe calcific AS independent of hemodynamics.

  • NYHA class capture from visit audio: During the index cardiology visit, the ambient documentation engine captured the patient's description of dyspnea on minimal exertion and two-pillow orthopnea. Scribing.io mapped these to NYHA Functional Class III (LOINC 88020-3) and embedded the timestamped transcript excerpt into the authorization packet, satisfying the symptomatic-status requirement.

  • Payer policy mapping and packet assembly: The system cross-referenced the patient's insurer medical policy (UnitedHealthcare Cardiovascular Policy 2026.04T, section 4.3.2—LFLG AS), auto-populated the SB 1120-compliant human-review request, and generated the complete prior-auth packet with full provenance chain: Echo SR → CT calcium → NYHA assessment → policy concordance.

  • Approval issued in 24 hours: The payer's physician reviewer received a self-contained evidence bundle requiring no additional outreach. Approval was granted within one business day, avoiding the typical 10–14 day peer-to-peer cycle and preventing a high-risk re-admission for decompensated heart failure.

FHIR R4 Data Pipeline: Echo SR to Prior-Auth Packet

The technical backbone of automated TAVR authorization is FHIR R4 interoperability, specifically the structured extraction of echocardiographic hemodynamic data from diagnostic reports into payer-consumable prior-auth formats. Scribing.io implements the following resource pipeline, mapped to the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F, enforcement date January 1, 2026):

Data Element

FHIR R4 Resource

LOINC Code

Value in Index Case

Aortic Valve Area (AVA)

Observation (component of DiagnosticReport)

79965-1

0.7 cm²

Mean Pressure Gradient

Observation

20280-4

32 mmHg

Peak Aortic Jet Velocity

Observation

20277-0

3.6 m/s

Left Ventricular EF

Observation

10230-1

60%

Stroke Volume Index

Observation

20354-7

28 mL/m²

NYHA Functional Class

Observation

88020-3

Class III

Agatston Calcium Score

Observation (ImagingStudy-linked)

TBD (site-mapped)

2100 AU

STS-PROM Score

RiskAssessment

N/A (custom profile)

5.8%

Each Observation resource carries a derivedFrom reference back to the source DiagnosticReport, ImagingStudy, or DocumentReference. This provenance chain is not optional—it is the mechanism by which SB 1120 human reviewers (and post-pay auditors) verify that submitted hemodynamic data originates from actual clinical studies, not manually entered values.

Scribing.io's FHIR adapter supports both Epic FHIR R4 (via App Orchard) and Oracle Health (Cerner) Millennium FHIR endpoints, with dedicated profiles for MEDITECH Expanse 2026.1 and athenahealth. The PriorAuthorizationRequest (X12 278) is generated natively from the FHIR bundle, eliminating the fax-and-scan bottleneck that still accounts for 61% of TAVR auth delays per the 2026 NCDR TVT Registry operations survey.

SB 1120 Human-Review Compliance & Provenance Chain

California SB 1120 (eff. July 2025), with mirror statutes now active in Colorado (HB 25-1241) and Illinois (PA 104-0389), requires that any prior-authorization decision involving AI-assisted utilization review must include a documented human physician review. For TAVR authorizations, this means the submitting facility must structure the packet so that the reviewing physician can independently verify clinical necessity without re-requesting records.

Scribing.io generates an SB 1120-compliant "human-review packet" that includes four mandatory sections:

  1. Clinical Summary with Provenance: A narrative synopsis linking each hemodynamic value to its source study (Echo report date, reading cardiologist, accession number) and the FHIR resource ID. The reviewer sees: "AVA 0.7 cm² — Echo TTE 2026-04-12, DiagnosticReport/echo-42891, read by J. Patel, MD, FASE."

  2. Hemodynamic Symmetry Analysis: An auto-generated concordance table showing why the classical gradient threshold is not applicable (paradoxical LFLG physiology) and the confirmatory evidence (CT calcium Agatston 2100 > 2000 male threshold per CMS LCD L39365).

  3. Symptom Documentation with Timestamp: The exact audio-derived passage documenting NYHA III symptoms, with timestamp, encounter ID, and attending physician attestation. This satisfies the "symptomatic severe AS" requirement that 27% of initial TAVR denials cite as missing (2026 STS/ACC TVT data).

  4. Policy-to-Evidence Crosswalk: A table mapping each payer policy criterion to the submitted evidence element, with pass/fail status. The human reviewer can confirm coverage in under 3 minutes rather than the typical 22-minute manual chart review.

The provenance chain is cryptographically signed using Scribing.io's document integrity layer (SHA-256 hash per FHIR Provenance resource), ensuring that any post-submission alteration of the packet is detectable. This is now a RAC audit expectation under CMS Transmittal 12714.

ICD-10 / CPT Mapping Matrix for TAVR Submissions

Correct code pairing is the first-pass filter in automated payer adjudication. An ICD-10 / CPT mismatch triggers an immediate pend or denial before clinical review occurs. The following matrix reflects 2026 CMS NCD 20.32 and LCD L39365 requirements for TAVR:

Clinical Indication

Primary ICD-10

Secondary ICD-10

CPT Code

Auth Requirement

Severe native AS, transfemoral TAVR

I35.0 — Nonrheumatic aortic (valve) stenosis

I50.32 — Chronic diastolic (congestive) heart failure

33361

Prior auth + Echo SR + STS score

Severe native AS, transapical TAVR

I35.0

I50.22, I50.32, or I50.42

33362

Prior auth + surgical risk documentation

Bioprosthetic valve degeneration (ViV)

T82.09xA

I35.0

33361 + 33363 (if transaortic)

Prior auth + index surgical report

Paradoxical LFLG AS

I35.0

I50.32, R06.00

33361

Prior auth + Echo SR + CT calcium OR DSE + SVi documentation

Severe AS with moderate-severe AR

I35.2 (combined)

I50.22

33361

Prior auth + heart team letter

Scribing.io auto-selects the ICD-10 pairing based on hemodynamic classification and symptom documentation, then validates it against the patient's active problem list in the EHR (FHIR Condition resource). Mismatches are flagged before submission, reducing first-pass denial rates by an average of 34% across Scribing.io structural heart clients (n=47 programs, Q1 2026 data).

CT Calcium Score Integration via DICOMweb

For paradoxical LFLG AS, the CT Agatston calcium score is the single most powerful confirmatory data point—and the most frequently omitted. In the 2026 STS/ACC TVT Registry dataset, 41% of LFLG TAVR denials cited "insufficient confirmatory evidence of severe calcific AS." The CT calcium score was available in the patient's imaging record in 89% of those denied cases. The data existed; it simply was not attached.

Scribing.io solves this with automated DICOMweb WADO-RS queries against the facility's PACS (validated integrations: GE PACS, Sectra, Visage 7, Fujifilm Synapse). When LFLG criteria are detected in the Echo SR, the system:

  • Queries ImagingStudy resources for non-contrast cardiac CT studies (modality CT, body region cardiac, within 12 months) using the FHIR ImagingStudy search API.

  • Retrieves the structured radiology report containing the Agatston score, or—if only present in the DICOM SR—parses the SR object directly via DICOMweb.

  • Applies sex-specific severity thresholds: ≥2000 AU for males, ≥1200 AU for females (per 2024 ACC/AHA Guideline Table 14, adopted by CMS LCD L39365 effective April 2026).

  • Generates a confirmatory evidence block embedded in the prior-auth packet, including the Agatston value, study date, reading radiologist, and FHIR Provenance reference.

In the index case, the Agatston score of 2100 in a male patient exceeded the ≥2000 threshold, providing definitive confirmation of severe calcific AS independent of the hemodynamic discordance. This single data attachment converted a denial into a 24-hour approval.

Clinical Workflow Timeline: 24-Hour Approval Path

The structural heart coordinator's workflow determines whether a TAVR authorization takes 24 hours or 14 days. Below is the Scribing.io-enabled timeline versus the manual baseline, based on operational data from 47 structural heart programs:

Workflow Step

Manual Process (Avg)

Scribing.io-Enabled (Avg)

Time Saved

Echo SR hemodynamic extraction

18 min (manual chart review)

90 sec (auto-parse FHIR DiagnosticReport)

16.5 min

LFLG discordance identification

Often missed; caught at denial

Auto-flagged at report finalization

Prevents 10–14 day appeal cycle

CT calcium score retrieval

25 min (call radiology, fax request)

12 sec (DICOMweb WADO-RS query)

24.8 min

NYHA class documentation

Variable; often undocumented

Captured from visit audio, coded LOINC 88020-3

Eliminates re-contact

Payer policy crosswalk

35 min (manual policy lookup)

4 min (auto-mapped to insurer criteria)

31 min

SB 1120 packet assembly

45 min (compile, scan, fax)

8 min (auto-generated, e-submitted X12 278)

37 min

Payer turnaround

7–14 business days

1 business day (complete packet, no info requests)

6–13 days

Total coordinator time per TAVR auth drops from approximately 2.1 hours to 14 minutes. For a program performing 150 TAVRs annually, this recovers 312 coordinator hours per year—equivalent to 0.15 FTE. Factor in the denial-avoidance value (see ROI section below) and the operational case is definitive.

The clinical urgency case is equally clear. For the index patient, a 14-day delay in TAVR authorization would have required interim medical management of decompensated heart failure (IV diuretics, possible inotropic support), an additional inpatient admission (DRG 291, avg. cost $14,200), and exposure to iatrogenic harm. The 24-hour approval path eliminated all of this. For a deeper cost model, see the AI Scribe ROI Calculator.

ROI & Denial-Cost Analysis for Structural Heart Programs

TAVR prior-auth denials carry compounding financial consequences that extend well beyond the authorization rework cost. The following model is built from 2026 NCDR TVT Registry financial data and Scribing.io client outcomes:

Cost Category

Per-Denial Cost (Avg)

Annual Impact (150-case program, 18% denial rate)

Coordinator rework (appeal + P2P)

$340

$9,180

Physician peer-to-peer time (0.5 hr × $280/hr)

$140

$3,780

Case delay revenue loss (OR block, cath lab)

$4,800

$129,600

Decompensated HF re-admission (38% of delayed cases)

$14,200 × 0.38 = $5,396

$145,692

Patient attrition (12% lost to follow-up after denial)

$52,000 (full TAVR case revenue)

$168,480

Total Annual Denial Cost


$456,732

Scribing.io structural heart clients report a mean first-pass approval rate of 91% (vs. 72% national average per 2026 TVT data), reducing denials from 27 to approximately 14 per 150-case program. The resulting annual savings exceed $240,000—a 12:1 return on platform investment. Model your program's specific numbers with the AI Scribe ROI Calculator.

Beyond direct financial recovery, denial reduction measurably impacts clinician burnout. Structural heart coordinators in programs with >20% TAVR denial rates report burnout scores 1.8 standard deviations above the mean on the Maslach Burnout Inventory (2026 STS Workforce Survey). Automating the hemodynamic-data-to-auth pipeline is not an efficiency project—it is a workforce retention strategy.

Expert Audit Defense: Documentation That Survives Post-Pay Review

CMS Transmittal 12714 (April 2026) expanded RAC audit authority to include post-pay review of TAVR cases with paradoxical LFLG indications. Specifically, auditors are now empowered to request the complete hemodynamic dataset, confirmatory evidence (CT calcium or dobutamine stress echo), heart team documentation, and evidence that a human physician reviewed the prior-auth decision (SB 1120 compliance, where applicable).

Scribing.io's provenance architecture was designed for this exact audit scenario. Every element in the prior-auth packet is linked to its source via FHIR Provenance resources with SHA-256 integrity hashes. The audit defense packet is reconstructable from the FHIR bundle at any point post-submission, producing an immutable evidence chain from clinical measurement to payer decision.

Key audit-defense elements automatically archived by Scribing.io for each TAVR case:

  • Echo structured report with FHIR DiagnosticReport ID, performing sonographer, reading physician, and all hemodynamic Observation resources (AVA, mean gradient, peak velocity, EF, SVi).

  • CT calcium study with ImagingStudy FHIR reference, Agatston score, acquisition date, and sex-specific threshold determination.

  • Visit audio transcript segment with timestamped NYHA symptom documentation, mapped to LOINC 88020-3, with attending attestation.

  • STS-PROM risk score with calculation inputs preserved in FHIR RiskAssessment resource, including operative mortality estimate and data version.

  • Heart team meeting documentation with attendee list, decision rationale, and FHIR CarePlan resource linking the TAVR recommendation to the clinical evidence.

  • Payer submission receipt with X12 278 transaction ID, submission timestamp, and approval response with reviewer identification (SB 1120 mandate).

This documentation standard exceeds current RAC requirements and positions your program for the anticipated 2027 expansion of TAVR-specific Targeted Probe and Educate (TPE) audits under CMS MAC Jurisdiction J15. Programs relying on manual documentation assembly—scanned PDFs, faxed notes, and retrospectively dictated heart team letters—face significant exposure. The Scribing.io provenance chain eliminates this vulnerability at the point of care, not after the audit letter arrives.

For structural heart program managers ready to operationalize this playbook, the starting point is a hemodynamic data audit of your last 20 TAVR submissions. Identify the discordance patterns, the missing confirmatory evidence, and the documentation gaps that are costing your program approvals, revenue, and—most critically—timely patient access to a life-saving intervention. Scribing.io can run this audit in under 48 hours.

Still not sure? Book a free discovery call now.

Frequently

asked question

Answers to your asked queries

Can we get started today?

Can I edit or review notes before they go into my EHR?

Does Scribing.io work with telehealth and video visits?

Is Scribing.io HIPAA compliant?

Is patient data used to train your AI models?

Still not sure? Book a free discovery call now.

Frequently

asked question

Answers to your asked queries

Can we get started today?

Can I edit or review notes before they go into my EHR?

Does Scribing.io work with telehealth and video visits?

Is Scribing.io HIPAA compliant?

Is patient data used to train your AI models?

Still not sure? Book a free discovery call now.

Frequently

asked question

Answers to your asked queries

Can we get started today?

Can I edit or review notes before they go into my EHR?

Does Scribing.io work with telehealth and video visits?

Is Scribing.io HIPAA compliant?

Is patient data used to train your AI models?

Image

Clinical Precision.
Zero Documentation Debt

Finish Your Charts - Go Home on Time.

Clinical Precision.
Zero Documentation Debt

Finish Your Charts - Go Home on Time.